Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

UK vets facing 'triple whammy', BVA warns
The report warns that veterinary surgeons could be taken away from statutory disease surveillance work to deliver export certificates.
Report raises serious concerns in the run-up to the Brexit transition period.

The UK veterinary profession could be facing a 'triple whammy' of Brexit, COVID-19 and exotic diseases, the British Veterinary Association (BVA) has warned.

In a new report, BVA assesses the readiness of the UK and raises serious questions concerns around veterinary capacity and infrastructure just weeks away from the end of the Brexit transition period (31 December).

It calls on the government to clarify the number of Official Veterinarians that will be needed to certify export health certificates (EHC) and to identify where in the country they will be required. 

The BVA has been raising concerns about veterinary capacity since the EU referendum, as around half of new vets registering in the UK each year are from the European Economic Area (EEA). It says that COVID-19 has placed additional pressure on veterinary capacity as fewer vets have come to work in the UK during 2020.

The report warns that veterinary surgeons could be taken away from statutory disease surveillance work (such as TB testing) to deliver essential export certification work and keep goods moving safely. It calls on the government to guarantee that statutory disease work will not be impacted by the resulting negative impacts on animal health and welfare.

The report also raises questions about preparations for pet travel and equine movements and highlights how veterinary diagnostic and research samples for CITES-listed species can be moved in a timely fashion between UK and EU laboratories. 

Moreover, the BVA's report warns of the high threat of some exotic diseases, such as avian influenza and African Swine Fever, potentially putting an additional strain on veterinary capacity. 

“The veterinary profession is absolutely critical to the safe trading of animals and animal products whether the UK reaches a deal with the EU or not,” commented BVA president James Russell. “With just weeks to go until the end of the transition period, we are deeply concerned that we still don't have clarity on exactly what will be required. 

“We're calling on the government to urgently send a strong signal to industry that it needs to recruit Official Veterinarians now to secure the necessary workforce. At a time when we need to be gearing up our capacity, our workforce is at full tilt under the shadow of COVID-19 restrictions and depleted by a reduction in registrations from overseas. This needs to be factored into plans.”

He continued: “Our biggest concern is that as we look to 2021, we face the threat of a triple whammy of COVID, Brexit and exotic disease. Vets will always prioritise animal health and welfare and public health, but we need government to give us the information we need to do so.”

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.